Literature DB >> 23061729

Peripheral mononuclear cell rejuvenation for senescence surveillance in Alzheimer disease.

Marco Malavolta1, Andrea Basso, Francesco Piacenza, Laura Costarelli, Robertina Giacconi, Eugenio Mocchegiani.   

Abstract

Recent observations have pointed out that microglia, astrocytes and cerebrovascular endothelial cells senescence might contribute to the onset or progression of sporadic AD. The accumulation of senescent dysfunctional microglia or senescence related changes of other cells within CNS could be causally implicated in AD and age-related dysfunction and their efficient removal could represent a pivotal mechanism to prevent or delay neurodegeneration. The question how senescent cells are cleared from CNS has been poorly investigated, even though it is reasonable to believe that resident microglia is involved in this task. However, accumulating evidence now support the idea that assistance by peripheral mononuclear phagocytes (MP) in AD could be essential to control local brain inflammation and remove Abeta depots. Based on the current knowledge it is reasonable to hypothesize that senescence surveillance might be among the tasks that blood derived MP are called to envelop in the CNS during particular conditions, especially in the case senescent microglia is not able to achieve this task properly. However, age-related dysfunctions of these players of innate immunity could lead to depict a series of events that synergically with microglia and other CNS cells senescence could lead to a rapid progression of the disease. Hence, the design of intervention aimed at targeting accumulating senescent cells by rejuvenation of peripheral MP function seems an attractive tool that perhaps would also help to clarify the processes involved in senescence surveillance in normal and AD brain.

Entities:  

Mesh:

Year:  2013        PMID: 23061729

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  3 in total

1.  Secreted miR-34a in astrocytic shedding vesicles enhanced the vulnerability of dopaminergic neurons to neurotoxins by targeting Bcl-2.

Authors:  Susu Mao; Qi Sun; Hui Xiao; Chenyu Zhang; Liang Li
Journal:  Protein Cell       Date:  2015-06-20       Impact factor: 14.870

2.  Differential chemokine expression under the control of peripheral blood mononuclear cells issued from Alzheimer's patients in a human blood brain barrier model.

Authors:  Julie Vérité; Guylène Page; Marc Paccalin; Adrien Julian; Thierry Janet
Journal:  PLoS One       Date:  2018-08-09       Impact factor: 3.240

3.  Dysfunctional macrophages in Alzheimer Disease: another piece of the "macroph-aging" puzzle?

Authors:  Laura Costarelli; Marco Malavolta; Robertina Giacconi; Mauro Provinciali
Journal:  Aging (Albany NY)       Date:  2017-08-05       Impact factor: 5.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.